Metraipolis › archive › dc_7e9036f78d3d

Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol — Europe PMC PMID:42097661

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42097661
DOI
10.1136/bmjopen-2025-111194
License (as archived)
solo-consultazione
Archived
2026-10-06T20:16:43.270Z
SHA-256 of the archived text
35d6b00cb222f1f29aeda9e29fa6d0ab792dd1b9d55edd3f28abedae09fc8207
Stable URL of this page
https://metraipolis.com/documento/dc_7e9036f78d3d

How to cite

Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol — Europe PMC PMID:42097661 — Europe PMC (en), https://europepmc.org/article/MED/42097661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e9036f78d3d (Metraipolis archive dc_7e9036f78d3d, sha256 35d6b00cb222f1f29aeda9e29fa6d0ab792dd1b9d55edd3f28abedae09fc8207)
BibTeX
@misc{dc7e9036f78d3d,
  title = {Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol — Europe PMC PMID:42097661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42097661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e9036f78d3d; sha256 35d6b00cb222f1f29aeda9e29fa6d0ab792dd1b9d55edd3f28abedae09fc8207},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42097661. Agents can read the archived copy with the MCP tool read_document.